How to Comply with China’s Advertising Law as a Foreign Brand: 2026 Practical Guide
China’s Advertising Law (广告法, guǎnggào fǎ) imposes over 37 specific prohibitions and fines of up to RMB 5,000,000 (approximately USD 685,000) for serious violations, making it one of the most stringent advertising regulatory frameworks globally. For foreign brands entering or operating in China, compliance is not optional—enforcement has intensified since the 2018 amendments, with the State Administration for Market Regulation (国家市场监督管理总局, SAMR, guójiā shìchǎng jiāndū guǎnlǐ zǒng jú) issuing over RMB 2.3 billion in fines in 2024 alone. This guide provides a practical, step-by-step roadmap for foreign executives to navigate China’s advertising rules in 2026, covering key prohibitions, comparative claims, influencer liability, and penalty structures.
Understanding the Legal Framework: Key Regulators and 2026 Updates
The primary regulatory body enforcing China’s advertising law is the SAMR at the national level, supported by local Market Supervision Bureaus (市场监管局, shìchǎng jiāndū jú) at the provincial and municipal levels. In 2026, two major updates came into effect: stricter rules on health-related product advertising and expanded liability for social media platforms hosting illegal ads. Foreign brands must also comply with the E-Commerce Law (电子商务法, diànzǐ shāngwù fǎ) and the Anti-Unfair Competition Law when advertising on platforms like Tmall, JD.com, and Douyin.
The law applies to all “advertisers” (广告主, guǎnggào zhǔ), “advertising operators” (广告经营者, guǎnggào jīngyíng zhě), and “publishers” (广告发布者, guǎnggào fābù zhě), including foreign companies and their local subsidiaries. Even if your brand uses a wholly foreign-owned enterprise (外商独资企业, WFOE, wàishāng dúzī qǐyè) to manage marketing, the WFOE is legally responsible for all advertising content it publishes or commissions within China.
The 2026 updates particularly impact foreign brands in three areas: mandatory pre-approval for medical, pharmaceutical, and certain food ads; a ban on using “national” or “most” qualifiers without verified data; and a requirement that all endorsers—including Key Opinion Leaders (KOLs)—must have used the product themselves before making claims. These changes mirror enforcement trends in the European Union’s Digital Services Act but with stricter penalties.
Prohibited Content and Absolute Terms: The “First, Best, Most” Trap
One of the most frequent compliance violations for foreign brands involves using absolute or superlative terms. Article 9 of the Advertising Law explicitly bans words like “nation’s first” (全国第一, quánguó dì yī), “best” (最佳, zuì jiā), “most advanced” (最先进, zuì xiānjìn), and “number one” (第一名, dì yī míng) unless the claim is backed by a government-issued certificate and a specific ranking methodology. Even then, the context must not mislead consumers.
Foreign brands often import global taglines—such as “The World’s Most Trusted Brand” or “Leading Innovation Since 1990″—without localizing for compliance. In 2025, a European luxury skincare brand was fined RMB 500,000 for using “best-selling serum in Europe” on its Tmall storefront because the claim could not be verified by Chinese authorities. The SAMR ruled the statement misleading under Chinese law, even though it was legally acceptable in the brand’s home market.
To avoid this pitfall, review all global campaign materials—including packaging, social media posts, and e-commerce listings—for superlatives. Replace banned terms with fact-based, verifiable descriptors such as “clinically tested on 200 volunteers” or “contains 95% naturally derived ingredients.” Pre-clear all claims with a local SAMR-approved advertising reviewer or a compliance lawyer specializing in Chinese advertising law.
Comparative Advertising and Data Claims: The Evidence Rule
Comparative advertising—directly naming a competitor or implying superiority—is permitted in China but subject to strict evidence requirements. Article 11 of the Advertising Law requires that all comparisons be “true, accurate, and based on verifiable data.” The data source must be disclosed, and the comparison must not denigrate the competitor’s reputation. In practice, this means you cannot say “Brand X lasts longer than Brand Y” unless you have a peer-reviewed study conducted by a Chinese-accredited institution that directly compares both products under identical conditions.
Foreign brands frequently run into trouble using international test results without local validation. For example, a Japanese electronics brand in 2024 claimed its air purifier “removes 99.97% of PM2.5 particles, outperforming leading competitors.” The local SAMR office demanded the raw test data, the testing methodology, and the competitor’s product model used in the comparison. When the brand could not produce a Chinese-language report, it was fined RMB 800,000 and forced to remove the ad within 48 hours.
Data claims must also appear in context. If you cite a survey showing “80% of users prefer this product,” the survey must be conducted among Chinese consumers, using a statistically significant sample, and the margin of error must be disclosed. The SAMR treats any omission as a “misleading advertisement” (虚假广告, xūjiǎ guǎnggào), which carries fines of three to five times the illegal advertising revenue.
Health, Beauty, and Food Claims: Special Category Rules
Products in health, beauty, and food categories face the strictest oversight. For “health food” (保健食品, bǎojiàn shípǐn) and “medical devices” (医疗器械, yīliáo qìxiè), all advertising must obtain pre-approval from the SAMR before publication, and the approval number must appear in the ad. The 2026 regulations expanded this requirement to include “functional foods” (功能性食品, gōngnéng xìng shípǐn) and certain cosmetics making skin-repair or anti-aging claims.
For cosmetics specifically, claims such as “whitening” (美白, měibái), “anti-wrinkle” (抗皱, kàngzhòu), or “sun protection” (防晒, fángshài) now require a Special Cosmetics Registration Certificate from the National Medical Products Administration (国家药品监督管理局, NMPA, guójiā yàopǐn jiāndū guǎnlǐ jú). Without this certificate, you cannot make any functional claim. A South Korean cosmetics brand was fined RMB 1,200,000 in early 2026 for using “brightens skin tone” in a Douyin ad without the required NMPA registration, as the phrase was deemed a functional claim rather than a general description.
For food products, Article 17 of the Advertising Law prohibits any claim that food has disease-prevention or treatment functions. Foreign brands selling imported snacks, beverages, or supplements must ensure that words like “detox,” “boosts immunity,” or “reduces inflammation” are removed from all Chinese-language materials, including packaging inserts and influencer scripts. The SAMR has issued at least 47 public warnings to foreign food brands since 2023, with fines averaging RMB 350,000 per violation.
Social Media, KOLs, and Influencer Marketing: Endorsement Liability
Influencer marketing is the highest-risk channel for foreign brands in China. Under Article 38 of the Advertising Law, endorsers—including KOLs, celebrities, and even virtual influencers—must have “actual use experience” with the product before making a recommendation. The law also holds the advertiser (the brand) jointly liable if the endorser makes a false claim. This joint liability means the brand and the KOL can be fined up to RMB 2,000,000, plus the illegal revenue earned from the campaign.
The 2026 updates added a “knowing participation” clause: if the brand knew or should have known the KOL had not used the product, the fine increases by 50%. Foreign brands must now require all KOL partners to sign compliance affidavits with proof of product usage (e.g., unboxing videos, purchase receipts, or usage logs). A foreign luxury watch brand learned this the hard way in late 2025 when its top KOL claimed he “wears this watch daily” in a livestream. An investigation revealed the KOL had only worn the watch for the photoshoot, and both parties were fined a combined RMB 1,800,000.
Additionally, all paid endorsements must be clearly labeled as “advertisement” (广告, guǎnggào) or “sponsorship” (赞助, zànzhù). The label must appear at the beginning of any video or post, not buried in the caption. Failure to disclose results in a separate fine of up to RMB 100,000 per post, plus platform-imposed penalties such as account suspension or reduced algorithmic reach.
Penalties and Enforcement: Real Financial Risk
China’s advertising law penalty structure is designed to deter non-compliance through escalating fines. The following table summarizes the key penalties foreign brands face in 2026:
| Violation Type | First Offense Fine (RMB) | Repeat Offense Fine (RMB) | Additional Consequences |
|---|---|---|---|
| Misleading advertisement (false claims) | 300,000 – 1,000,000 | 1,000,000 – 5,000,000 | Forced ad removal, public rectification notice, up to 3-year ad ban |
| Use of banned absolute terms | 200,000 – 500,000 | 500,000 – 2,000,000 | Product recall, e-commerce listing suspension |
| Unauthorized health/functional claims | 500,000 – 2,000,000 | 2,000,000 – 5,000,000 | Revocation of advertising pre-approval, business license warning |
| Undisclosed paid endorsement | 50,000 – 100,000 per instance | 100,000 – 300,000 per instance | Platform delisting, KOL blacklisting |
| Failure to obtain pre-approval (health/medical) | 1,000,000 – 3,000,000 | 3,000,000 – 6,000,000 | Criminal referral for willful violations |
Beyond fines, the SAMR can issue a “public rectification order” (责令改正, zélìng gǎizhèng) requiring the brand to publish a corrective statement in the same media channel as the original ad—at the brand’s own cost. For foreign brands, this reputational damage often exceeds the fine. In one 2024 case, a U.S. baby formula brand spent RMB 1,500,000 on corrective ads after a false immunity claim was flagged, significantly more than the RMB 800,000 fine.
Decision Framework: Choose Your Compliance Approach
If your brand sells directly to consumers through e-commerce platforms like Tmall or JD.com, choose a centralized pre-approval workflow where every ad, product page, and influencer script is reviewed by a compliance officer before publication. If your brand operates in B2B industrial goods or professional services, choose a self-certification checklist aligned with SAMR’s category-specific guidelines, as B2B claims face less scrutiny than B2C claims.
If your brand uses more than three KOLs per month, choose a contract-based compliance system that includes endorsement affidavits, label-disclosure templates, and quarterly training. If your brand runs no influencer campaigns, choose a post-launch monitoring system that audits ads quarterly against SAMR’s published violation database.
If your brand imports health foods or cosmetics, choose NMPA pre-approval registration before any marketing activity—this takes 6–12 months and is non-negotiable. If your brand imports general consumer goods with no health claims, choose advertising self-review with a local SAMR-approved third-party audit once per year.
Three Critical Pitfalls for Foreign Brands
NEXT STEPS
- Download our China Advertising Law Compliance Checklist for Foreign Brands to audit your current campaigns against 2026 regulations.
- Review our KOL Endorsement Compliance Guide: Contract Clauses and Disclosure Templates to protect your influencer marketing budget.
- Schedule a Free 30-Minute Compliance Assessment with Our SAMR-Registered Partner to identify high-risk ads in your current portfolio.
— China Gateway 360 —
Remote China market entry support, built around execution.
